Shanghai Tianwei Biopharmaceutical

Shanghai Tianwei Biopharmaceutical, also known as Shanghai Techwell Biopharmaceutical, is a Chinese pharmaceutical company specializing in the research, development, and commercial manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Founded in 2001 and operating as a subsidiary of Shanghai Shyndec Pharmaceutical under the Sinopharm Group, the company leverages advanced platforms in biological extraction, microbial fermentation, and chemical synthesis. Its commercial product portfolio primarily targets three therapeutic areas: assisted reproduction (including human chorionic gonadotropin, human menopausal gonadotropin, and follicle-stimulating hormone), antifungals (such as micafungin sodium and caspofungin acetate), and prostaglandins for ophthalmic indications (including latanoprost and bimatoprost). The company operates state-of-the-art, GMP-certified manufacturing facilities in Shanghai's Xinzhuang Industrial Zone to supply high-quality products to both domestic and international markets.